ZBNA
PCVX icon

Zions Bancorporation, National Association’s Vaxcyte PCVX Stock Holding History

Zions Bancorporation, National Association’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-77
Closed -$4.47K – 1698
2026
Q1 		$4.47K Buy
+77
New +$4.18K ﹤0.01% 1024

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Zions Bancorporation, National Association's PCVX Position: Q2 2026 in Review

Zions Bancorporation, National Association sold out of Vaxcyte (PCVX) in Q2 2026, closing a stake of 77 shares — an estimated $4.47K sold.

Zions Bancorporation, National Association first reported a position in PCVX in Q1 2026 and held it in 1 quarter. The position peaked at $4.47K in Q1 2026. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Zions Bancorporation, National Association reported no remaining Vaxcyte position as of Q2 2026 after selling out during the quarter.
  • Zions Bancorporation, National Association sold 77 Vaxcyte shares in Q2 2026, an estimated $4.47K.
  • Zions Bancorporation, National Association first reported a position in Vaxcyte in Q1 2026 and held it in 1 quarter.
  • Zions Bancorporation, National Association's Vaxcyte position peaked at $4.47K in Q1 2026.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.